We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Phenotypic versus Target-based Screening for Drug Discovery

Article   Apr 24, 2018 | by Joanna Owens, PhD, Freelance Writer and Editor, UK

 
Phenotypic versus Target-based Screening for Drug Discovery
 
 
 

RELATED ARTICLES

Addressing Gender Bias – “It Is Time to End the Tradition in Science of All-Male Speaking Panels”

Article

Francis S. Collins, M.D., Ph.D. Director of the National Institutes of Health, has recently directly addressed the issue of underrepresented groups in science: "Too often, women and members of other groups underrepresented in science are conspicuously missing in the marquee speaking slots at scientific meetings and other high-level conferences.”

READ MORE

Data Visualization in Biopharma: Leveraging AI, VR and MR to Support Drug Discovery

Article

This article dwells upon the challenges presented by prevailing data visualization solutions for drug discovery and covers how enablers such as AI and VR have transformed the drug discovery data visualization market. It touches upon examples of existing solutions, new players and upcoming industry partnerships.

READ MORE

A Microfluidic Valley is Growing in Europe, and You’re Invited

Article

A story of the Elvesys Innovation Unit, a research institute in France designed to unite entrepreneurs involved in microfluidics research.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE